IGSF1 Deficiency Results in Human and Murine Somatotrope Neurosecretory Hyperfunction

Archive ouverte

Joustra, Sjoerd | Roelfsema, Ferdinand | van Trotsenburg, A.S.P. | Schneider, Harald | Kosilek, Robert | Kroon, Herman, M | Logan, John | Butterfield, Natalie | Zhou, Xiang | Toufaily, Chirine | Bak, Beata | Turgeon, Marc-Olivier | Brûlé, Emilie | Steyn, Frederik, J. | Gurnell, Mark | Koulouri, Olympia | Le Tissier, Paul | Fontanaud, Pierre | Bassett, Jh Duncan | Williams, Graham, R | Oostdijk, Wilma | Wit, Jan | Pereira, Alberto | Biermasz, Nienke | Bernard, Daniel, J | Schoenmakers, Nadia

Edité par CCSD ; Endocrine Society -

International audience. Context: The X-linked immunoglobulin superfamily, member 1 (IGSF1), gene is highly expressed in the hypothalamus and in pituitary cells of the POU1F1 lineage. Human loss-of-function mutations in IGSF1 cause central hypothyroidism, hypoprolactinemia, and macroorchidism. Additionally, most affected adults exhibit higher than average IGF-1 levels and anecdotal reports describe acromegaloid features in older subjects. However, somatotrope function has not yet been formally evaluated in this condition.Objective: We aimed to evaluate the role of IGSF1 in human and murine somatotrope function.Patients, Design, and Setting: We evaluated 21 adult males harboring hemizygous IGSF1 loss-of-function mutations for features of GH excess, in an academic clinical setting.Main Outcome Measures We compared biochemical and tissue markers of GH excess in patients and controls, including 24-hour GH profile studies in 7 patients. Parallel studies were undertaken in male Igsf1-deficient mice and wild-type littermates. Results IGSF1-deficient adult male patients demonstrated acromegaloid facial features with increased head circumference as well as increased finger soft-tissue thickness. Median serum IGF-1 concentrations were elevated, and 24-hour GH profile studies confirmed 2- to 3-fold increased median basal, pulsatile, and total GH secretion. Male Igsf1-deficient mice also demonstrated features of GH excess with increased lean mass, organ size, and skeletal dimensions and elevated mean circulating IGF-1 and pituitary GH levels.Conclusions We demonstrate somatotrope neurosecretory hyperfunction in IGSF1-deficient humans and mice. These observations define a hitherto uncharacterized role for IGSF1 in somatotropes and indicate that patients with IGSF1 mutations should be evaluated for long-term consequences of increased GH exposure.

Suggestions

Du même auteur

Response to Letter to the Editor: “IGSF1 Deficiency Results in Human and Murine Somatotrope Neurosecretory Hyperfunction”

Archive ouverte | Joustra, Sjoerd | CCSD

Réponse à une lettre à l'éditeur. International audience

A trans-eQTL network regulates osteoclast multinucleation and bone mass

Archive ouverte | Pereira, Marie | CCSD

International audience. Functional characterisation of cell-type-specific regulatory networks is key to establish a causal link between genetic variation and phenotype. The osteoclast offers a unique model for inter...

Pituitary Neoplasm Nomenclature Workshop: Does Adenoma Stand the Test of Time?

Archive ouverte | Ho, Ken | CCSD

International audience. Abstract The WHO Classification of Endocrine Tumours designates pituitary neoplasms as adenomas. A proposed nomenclature change to pituitary neuroendocrine tumors (PitNETs) has been met with ...

Chargement des enrichissements...